Advertisement
About Vical
Vical researches and develops biopharmaceutical products based on itspatented DNA delivery technologies for the prevention and treatment of seriousor life-threatening diseases. Potential applications of the company's DNAdelivery technology include DNA vaccines for infectious diseases or cancer, inwhich the expressed protein is an immunogen; cancer immunotherapeutics, inwhich the expressed protein is an immune system stimulant; and cardiovasculartherapies, in which the expressed protein is an angiogenic growth factor. Thecompany is developing certain infectious disease vaccines and cancertherapeutics internally. In addition, the company collaborates with majorpharmaceutical companies and biotechnology companies that give it access tocomplementary technologies or greater resources. These strategic partnershipsprovide the company with mutually beneficial opportunities to expand itsproduct pipeline and address significant unmet medical needs. Additionalinformation on Vical is available at http://www.vical.com.
Advertisement
This press release contains forward-looking statements subject to risksand uncertainties that could cause actual results to differ materially fromthose projected. Forward-looking statements include statements about thecompany's focus, collaborative partners, product candidates, and developmentalstatus. Risks and uncertainties include whether any product candidates will beshown to be safe and efficacious in clinical trials, the timing of clinicaltrials, whether Vical or its collaborative partners will seek or gain approvalto market any product candidates, the dependence of the company on itscollaborative partners, and additional risks set forth in the company'sfilings with the Securities and Exchange Commission. These forward-lookingstatements represent the company's judgment as of the date of this release.The company disclaims, however, any intent or obligation to update theseforward-looking statements.
Contact: Alan R. Engbring(858) 646-1127 Website: http://www.vical.com
SOURCE Vical Incorporated
